Radnet SEC Filings

RadNet, Inc. reported an insider stock transaction by an executive who serves as Executive Vice President and Chief Legal Officer. On 12/10/2025, this reporting person exercised employee stock options to acquire 3,396 shares of RadNet common stock at an exercise price of $29.44 per share, bringing their directly held common stock to 71,577 shares.

The exercised options are part of a grant originally issued on January 4, 2022 for up to 29,140 shares, subject to time-based vesting. One-third vested on January 4, 2022, with the remaining two-thirds vesting in three equal installments on January 3, 2023, January 3, 2024, and January 3, 2025. After this transaction, the reporting person continues to beneficially own 15,556 employee stock options, which are scheduled to expire on January 3, 2032.

RadNet, Inc. reported that a company officer serving as executive vice president of financial planning and chief accounting officer disposed of shares of common stock through a gift on December 3, 2025. The officer transferred 630 shares of RadNet common stock at a reported price of $0, consistent with a non-cash gift. After this transaction, the officer directly beneficially owned 179,508 shares of RadNet common stock.

RadNet, Inc. (RDNT) disclosed that its President, CEO and director exercised previously granted stock options and acquired additional common shares. On 11/19/2025, he exercised options to buy 103,969 shares of common stock at an exercise price of $18.64 per share, increasing his directly held stake to 322,420 shares. On the same date, he exercised another block of options for 25,992 shares at $18.64, bringing his direct holdings to 348,412 shares.

The filing shows an additional 20,000 shares of RadNet common stock held indirectly through his spouse. The options exercised were originally granted on January 3, 2023 as retention awards, with vesting tied to continued service and, for one grant, to RadNet’s fiscal year 2023 performance, which resulted in 100% performance-based vesting.

RadNet, Inc. (RDNT) executive EVP of Financial Planning and Chief Accounting Officer reported multiple open-market sales of company common stock. On 11/17/2025, the executive sold 25,000 shares at a weighted average price of $76.06. On 11/18/2025, a further 9,920 shares were sold at a weighted average price of $80.00, followed by 15,080 shares sold on 11/19/2025 at a weighted average price of $80.05. After these transactions, the reporting person directly beneficially owns 180,138 shares of RadNet common stock.

RadNet, Inc. executive vice president of mergers and acquisitions reported a stock gift on a Form 4. On 11/13/2025, the officer disposed of 3,000 shares of RadNet common stock in a transaction coded “G,” which indicates a bona fide gift. Following this transaction, the reporting person directly held 40,084 shares of RadNet common stock. The filing reflects an insider ownership change rather than any corporate action by the company.

RadNet (RDNT) reported Q3 2025 results with stronger top-line but mixed profitability. Total service revenue was $522.9 million, up from $461.1 million a year ago, led by higher commercial and Medicare volumes, while revenue under capitation arrangements eased to $31.4 million from $33.6 million. Diluted EPS was $0.07 versus $0.04, as interest expense declined and other income increased, including $8.9 million of interest on securities. Operating income was $27.4 million compared with $33.9 million, reflecting higher operating costs and $2.8 million of lease abandonment charges.

Year-to-date, revenue reached $1.49 billion; net loss to common was $(18.1) million. Operating cash flow was strong at $214.7 million, funding capex of $162.2 million and acquisitions of $66.5 million. RadNet ended the quarter with cash of $804.7 million and long-term notes payable of $1.07 billion. Shares outstanding were 77,032,154 as of September 30, 2025; 77,146,342 were outstanding on November 7, 2025.

Strategically, RadNet closed the iCAD acquisition (1,848,152 shares valued at $105.8 million) and bought AI firm See‑Mode with up to $12.7 million in milestone payments; it also acquired Kolb Radiology with up to $8.0 million earnout. Goodwill rose to $827.5 million.

RadNet, Inc. filed a prospectus supplement to its automatic shelf registration on Form S-3, registering for resale by selling stockholders up to 59,444 shares of its common stock. The filing states the shares may be sold from time to time by the referenced holders.

The company also filed a legal opinion from Reed Smith LLP covering the validity of the registered securities, included as Exhibit 5.1.

RadNet, Inc. registered 59,444 shares of common stock for resale by selling stockholders tied to its acquisition of substantially all assets of Remote Diagnostic Imaging Partners (RDIP). The registered amount includes 56,472 Initial Shares issued at closing on October 1, 2025 and up to 2,972 Holdback Shares withheld for 12 months to secure RDIP indemnification obligations.

RadNet will not receive any proceeds from these sales; any proceeds go to the selling stockholders. Sales may occur via ordinary brokerage transactions, block trades, privately negotiated deals, hedging, or short sales after the registration statement is declared effective. The company will bear registration expenses, while selling holders cover selling commissions and related costs.

As context, shares outstanding were 77,101,597 as of October 15, 2025. The RDIP purchase price was approximately $4.5 million, consisting of the share consideration and assumed liabilities, plus reimbursements of $5,700 and $13,000. Examples of per‑holder amounts being offered include Neil G. Huber 14,861 and Peter G. Jablonka 14,861. RadNet’s stock last closed at $76.93 on October 17, 2025 under “RDNT.”